These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2216210)
1. Carbon dioxide laser vaporization of diaphragmatic metastases for cytoreduction of ovarian epithelial cancer. Patsner B Obstet Gynecol; 1990 Oct; 76(4):724-7. PubMed ID: 2216210 [TBL] [Abstract][Full Text] [Related]
2. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related]
3. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases. Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM Gynecol Oncol; 2000 Aug; 78(2):171-5. PubMed ID: 10926798 [TBL] [Abstract][Full Text] [Related]
5. Full-thickness diaphragmatic resection with simple and secure closure to accomplish complete cytoreductive surgery for patients with ovarian cancer. Silver DF Gynecol Oncol; 2004 Nov; 95(2):384-7. PubMed ID: 15491761 [TBL] [Abstract][Full Text] [Related]
6. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927 [TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognostic factors for stage IV epithelial ovarian cancer]. Wu M; Shen K; Lang J Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158 [TBL] [Abstract][Full Text] [Related]
8. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery. Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534 [TBL] [Abstract][Full Text] [Related]
9. Surgical approach to diaphragmatic metastases from ovarian cancer. Deppe G; Malviya VK; Boike G; Hampton A Gynecol Oncol; 1986 Jun; 24(2):258-60. PubMed ID: 3710270 [TBL] [Abstract][Full Text] [Related]
10. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [TBL] [Abstract][Full Text] [Related]
11. [Surgical removal of diaphragmatic metastasis of advanced ovarian cancer. Review of the literature]. Rodier JF; Janser JC; Rodier D Rev Fr Gynecol Obstet; 1991 Jan; 86(1):39-42. PubMed ID: 2068484 [TBL] [Abstract][Full Text] [Related]
12. Thoracoscopy for the management of advanced epithelial ovarian cancer--a preliminary report. Eisenkop SM Gynecol Oncol; 2002 Feb; 84(2):315-20. PubMed ID: 11812093 [TBL] [Abstract][Full Text] [Related]
13. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Chi DS; Franklin CC; Levine DA; Akselrod F; Sabbatini P; Jarnagin WR; DeMatteo R; Poynor EA; Abu-Rustum NR; Barakat RR Gynecol Oncol; 2004 Sep; 94(3):650-4. PubMed ID: 15350354 [TBL] [Abstract][Full Text] [Related]
14. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Bristow RE; Montz FJ Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412 [TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Aletti GD; Dowdy SC; Podratz KC; Cliby WA Gynecol Oncol; 2006 Feb; 100(2):283-7. PubMed ID: 16182350 [TBL] [Abstract][Full Text] [Related]
16. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548 [TBL] [Abstract][Full Text] [Related]
17. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]